Ann Surg Oncol 2023 May 19
Survival and Symptomatic Relief After Cytoreductive Hepatectomy for Neuroendocrine Tumor Liver Metastases: Long-Term Follow-up Evaluation of More Than 500 Patients.
Related Questions
New comment by Medical Oncologist at Mayo Clinic ( September 11, 2023)
I would be careful with a h/o SBO, especially of peritoneal mets, and perhaps be more inclined to start therapy but if there was a cause of the SBO (tumor, adhesions, fibrosis...